The risk of ovarian malignancy algorithm (ROMA) incorporates cancer antigen 125 (CA125), human epididymal protein 4 (HE4), and menopausal status to assign women that present with an adnexal mass into a high-risk or low-risk group for finding an ovarian malignancy

Categories: ,


Method: CMIA
Price: 3000.00
Report: Sample Mon / Thu by 4 pm; Report Same day
Usage: Risk of Ovarian Malignancy algorithm (ROMA) test is used as an aid in assessing the risk of Ovarian cancer in women with a pelvic mass based on patient’s HE4 & CA125 levels and their menopausal status. Women with ROMA levels above their cutoff have an increased risk of Ovarian cancer. ROMA must be interpreted in conjunction with clinical & radiological assessment.
Doctor Specialty: Oncologist, Gynecologist
Disease: Cancer-Ovarian
Components: *CA125 *HE4 *Menopausal status risk estimation
Courier Charges: 0.00
Home Collection: Available
Pre Test Information: Provide menopausal status of the patient.